TDN World Desk: When India is busy in organising protests, carrying out debates and discussion on Citizenship Amendment Act, The National Pharmaceutical Pricing Authority (NPPA) allowed the manufacturer to raise the price of 21 essential life saving medicines by 50 percent.

Many pharmaceutical companies were lobbying for this price increase with the rise of active pharmaceutical ingredients (APIs), repoted CNBCTV18.

NPPA said that the price increase was based on a recommendation by the Standing Committe.

These essential medicines include Bacillus Calmette–Guérin (BCG) vaccine, anti-malaria drug Chloroquine, anti-leprosy drug Dapsone, the antibiotic Metronidazole, and vitamin C among others.

“The one time 50% price increase is arbitrary and lacks application of mind. The Government needs to put in place a system for monitoring API prices and fluctuations,” S. Srinivasan, co-convenor, All India Drug Action Network (AIDAN) said in a statement as quoted by lIveMint.

AIDAN is fighting a case in the Supreme Court against the government seeking the use of cost-based pricing for capping prices of essential medicines instead of the market-based pricing as it is done now.